GE HealthCare Technologies Inc. $GEHC Position Decreased by Mizuho Markets Americas LLC

Mizuho Markets Americas LLC cut its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 39.0% in the 4th quarter, HoldingsChannel reports. The firm owned 1,958,300 shares of the company’s stock after selling 1,250,700 shares during the period. GE HealthCare Technologies makes up 3.1% of Mizuho Markets Americas LLC’s portfolio, making the stock its 7th biggest position. Mizuho Markets Americas LLC’s holdings in GE HealthCare Technologies were worth $160,620,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Western Wealth Management LLC increased its holdings in shares of GE HealthCare Technologies by 2.4% in the 4th quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock worth $430,000 after buying an additional 125 shares during the last quarter. United Community Bank lifted its holdings in shares of GE HealthCare Technologies by 10.2% in the 4th quarter. United Community Bank now owns 1,410 shares of the company’s stock worth $116,000 after acquiring an additional 130 shares during the last quarter. Thoma Capital Management LLC boosted its stake in shares of GE HealthCare Technologies by 1.4% in the 4th quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock valued at $814,000 after purchasing an additional 136 shares in the last quarter. Colonial Trust Advisors grew its holdings in shares of GE HealthCare Technologies by 11.1% during the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock valued at $104,000 after purchasing an additional 139 shares during the last quarter. Finally, Norinchukin Bank The grew its holdings in shares of GE HealthCare Technologies by 0.4% during the 3rd quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock valued at $2,922,000 after purchasing an additional 149 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on GEHC. Mizuho reduced their price objective on GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. Piper Sandler lowered their target price on GE HealthCare Technologies from $88.00 to $74.00 in a research note on Thursday, April 30th. Stifel Nicolaus set a $80.00 target price on GE HealthCare Technologies in a report on Wednesday, April 29th. Citigroup reduced their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research report on Thursday, April 30th. Finally, Barclays decreased their price target on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 30th. Nine equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.21.

GE HealthCare Technologies Stock Down 0.2%

Shares of GE HealthCare Technologies stock opened at $64.23 on Friday. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The company has a market cap of $29.22 billion, a P/E ratio of 15.37, a PEG ratio of 1.45 and a beta of 0.74. The company’s fifty day simple moving average is $68.45 and its two-hundred day simple moving average is $76.24.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Insider Activity at GE HealthCare Technologies

In related news, insider Frank R. Jimenez acquired 1,750 shares of the stock in a transaction on Thursday, April 30th. The stock was acquired at an average price of $60.45 per share, for a total transaction of $105,787.50. Following the completion of the purchase, the insider owned 93,932 shares of the company’s stock, valued at $5,678,189.40. This represents a 1.90% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Peter J. Arduini purchased 4,169 shares of the stock in a transaction dated Thursday, April 30th. The stock was bought at an average cost of $59.92 per share, with a total value of $249,806.48. Following the transaction, the chief executive officer owned 259,424 shares in the company, valued at $15,544,686.08. The trade was a 1.63% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought a total of 11,847 shares of company stock worth $719,555 over the last 90 days. 0.36% of the stock is currently owned by insiders.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.